{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-ST Linezolid",
        "VITEK 2 Streptococcus Linezolid"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K111599",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "August 12, 2011",
    "Summary Letter Received Date": "June 8, 2011",
    "Submission Date": "June 3, 2011",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Linezolid susceptibility"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) microdilution methodology"
    ],
    "Methodologies": [
        "Qualitative susceptibility testing",
        "Miniaturized doubling dilution technique"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for bioM\u00e9rieux VITEK 2 AST-ST Linezolid qualitative susceptibility assay for Streptococcus species on VITEK 2 platforms",
    "Indications for Use Summary": "For antimicrobial susceptibility testing of Streptococcus species, aiding in the determination of in vitro susceptibility to linezolid using the VITEK 2 and VITEK 2 Compact Systems",
    "fda_folder": "Microbiology"
}